Revisto Secures $4M Seed Funding to Revolutionize Pharma Marketing
Slice of Healthcare Team
Nov 21, 2024
Key Highlights
- Revisto secures $4M in seed funding led by LiveOak Ventures, joined by Eli Lilly and others.
- AI-driven platform reduces time and costs in MLR review processes for pharma marketing.
- Estimates $15M+ in annual savings per brand with faster compliance workflows.
- Seamless integration with tools like Veeva Vault PromoMats ensures operational compatibility.
- Total funding now stands at $6M, supporting team expansion and product development.
Source: Business Wire
Notable Quotes
“ This funding validates the transformative potential of Revisto’s AI-driven solution in the pharmaceutical industry and offers early adopters a significant time-to-market edge. ”
Ferry Tamtoro, CEO at Revisto
“ Revisto empowers the industry to accelerate the delivery of life-changing products while controlling costs. ”
Venu Shamapant, Founding Partner at LiveOak Ventures
